[1] |
Kojima M, Hosoda H, Date Y,et al.Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402: 656-660.
|
[2] |
Stasi and Milani C. Functions of Ghrelin in Brain, Gut and Liver. CNS Neurol Disord Drug Targets, 2016,15: 956-963.
|
[3] |
Obay BD, Ta demir E, Tümer C, et al. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides, 2008, 29: 448-455.
|
[4] |
Sun N, Wang H, Wang L. Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-κB pathway. Mol Med Rep, 2016, 14: 2764-2770.
|
[5] |
Mao Y, Cheng J, Yu F, et al. Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-κB inhibition. Cell Physiol Biochem, 2015, 37: 563-576.
|
[6] |
Moreno M, Chaves JF, Sancho-Bru P, et al. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology, 2010, 51: 974-985.
|
[7] |
Liu Y, Dai M, Bi Y, et al. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol, 2013, 23: 115-121.
|
[8] |
Goh GB, McCullough AJ. Natural history of nonalcoholic fatty liver disease. Dig Dis Sci, 2016, 61: 1226-1233.
|
[9] |
Golestan Jahromi M, Nabavizadeh F, Vahedian J, et al. Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides, 2010, 31: 2114-2117.
|
[10] |
Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis, 2010, 9: 42.
|
[11] |
韩玲玲, 张晓蕾, 陈颖, 等. Ghrelin 对高脂环境下大鼠成肌细胞糖脂代谢的影响. 中国医科大学学报, 2011, 40: 885-887.
|
[12] |
Li Z, Xu G, Qin Y, et al. Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway. Proc Natl Acad Sci USA, 2014, 111: 13163-13168.
|
[13] |
Buyse J, Janssen S, Geelissen S, et al. Ghrelin modulates fatty acid synthase and related transcription factor mRNA levels in a tissue-specific manner in neonatal broiler chicks. Peptides, 2009, 30: 1342-1347.
|
[14] |
Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology, 2010, 52: 774-788.
|
[15] |
Zeng M, He W, Li L, et al. Ghrelin attenuates sepsis-associated acute lung injury oxidative stress in rats. Inflammation, 2015, 38: 683-690.
|
[16] |
Zeng L, Tang WJ, Yin JJ, et al. Signal transductions and nonalcoholic fatty liver: a mini-review. Int J Clin Exp Med, 2014, 7: 1624-1631.
|
[17] |
Matsuda S, Kobayashi M, Kitagishi Y. Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease. ISRN Endocrinol, 2013, 2013.
|
[18] |
Han JW, Zhan XR, Li XY, et al. Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World J Gastroenterol, 2010, 16: 6111-6118.
|
[19] |
Saidi Y, Hearn TJ, Coates JC. Function and evolution of ‘green’ GSK3/Shaggy-like kinases. Trends Plant Sci, 2012, 17: 39-46.
|
[20] |
Banko NS, McAlpine CS, Venegas-Pino DE, et al. Glycogen Synthase Kinase 3α Deficiency Attenuates Atherosclerosis and Hepatic Steatosis in High Fat Diet-Fed Low Density Lipoprotein Receptor-Deficient Mice. Am J Pathol, 2014, 184: 3394-3404.
|
[21] |
Mao Y, Wang J, Yu F, et al. Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice. Drug Des Devel Ther,2015, 9: 5385-5396.
|